These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38775200)

  • 1. Emerging therapies in Ewing sarcoma.
    Strauss SJ; Berlanga P; McCabe MG
    Curr Opin Oncol; 2024 Jul; 36(4):297-304. PubMed ID: 38775200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ewing Sarcoma Drug Therapy: Current Standard of Care and Emerging Agents.
    Setty BA; Gikandi A; DuBois SG
    Paediatr Drugs; 2023 Jul; 25(4):389-397. PubMed ID: 37014523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical Interference of the EWS-FLI1-driven Transcriptome By Cotargeting H3K27ac and RNA Polymerase Activity in Ewing Sarcoma.
    Heisey DAR; Jacob S; Lochmann TL; Kurupi R; Ghotra MS; Calbert ML; Shende M; Maves YK; Koblinski JE; Dozmorov MG; Boikos SA; Benes CH; Faber AC
    Mol Cancer Ther; 2021 Oct; 20(10):1868-1879. PubMed ID: 34315769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision medicine in Ewing sarcoma: a translational point of view.
    Gargallo P; Juan A; Yáñez Y; Dolz S; Segura V; Castel V; Cañete A
    Clin Transl Oncol; 2020 Sep; 22(9):1440-1454. PubMed ID: 32026343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical heterogeneity of round cell sarcomas with EWSR1/FUS gene fusions: Impact of gene fusion type on clinical features and outcome.
    Tsuda Y; Zhang L; Meyers P; Tap WD; Healey JH; Antonescu CR
    Genes Chromosomes Cancer; 2020 Sep; 59(9):525-534. PubMed ID: 32362012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary subcutaneous spindle cell Ewing sarcoma with strong S100 expression and EWSR1-FLI1 fusion: a case report.
    Arnold MA; Ballester LY; Pack SD; Abdullaev Z; Merchant M; Tsokos MG
    Pediatr Dev Pathol; 2014; 17(4):302-7. PubMed ID: 24735198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ewing sarcoma: investigational mono- and combination therapies in clinical trials.
    Gartrell J; Rodriguez-Galindo C
    Expert Opin Investig Drugs; 2021 Jun; 30(6):653-663. PubMed ID: 33870845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma.
    Loganathan SN; Tang N; Fleming JT; Ma Y; Guo Y; Borinstein SC; Chiang C; Wang J
    Oncotarget; 2016 Jul; 7(28):43504-43517. PubMed ID: 27259270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the undruggable: exploiting neomorphic features of fusion oncoproteins in childhood sarcomas for innovative therapies.
    Knott MML; Hölting TLB; Ohmura S; Kirchner T; Cidre-Aranaz F; Grünewald TGP
    Cancer Metastasis Rev; 2019 Dec; 38(4):625-642. PubMed ID: 31970591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Functional genomics of Ewing sarcoma].
    Grünewald TGP
    Pathologe; 2017 Nov; 38(Suppl 2):198-201. PubMed ID: 28849372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual targeting of EWS-FLI1 activity and the associated DNA damage response with trabectedin and SN38 synergistically inhibits Ewing sarcoma cell growth.
    Grohar PJ; Segars LE; Yeung C; Pommier Y; D'Incalci M; Mendoza A; Helman LJ
    Clin Cancer Res; 2014 Mar; 20(5):1190-203. PubMed ID: 24277455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential approaches to the treatment of Ewing's sarcoma.
    Yu H; Ge Y; Guo L; Huang L
    Oncotarget; 2017 Jan; 8(3):5523-5539. PubMed ID: 27740934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?
    Danieau G; Morice S; Rédini F; Verrecchia F; Royer BB
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EWSR1-FLI1 Activation of the Cancer/Testis Antigen FATE1 Promotes Ewing Sarcoma Survival.
    Gallegos ZR; Taus P; Gibbs ZA; McGlynn K; Gomez NC; Davis I; Whitehurst AW
    Mol Cell Biol; 2019 Jul; 39(14):. PubMed ID: 31036566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the Treatment of Pediatric Bone Sarcomas.
    Grohar PJ; Janeway KA; Mase LD; Schiffman JD
    Am Soc Clin Oncol Educ Book; 2017; 37():725-735. PubMed ID: 28561686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. iPSC-Derived Neoantigen-Specific CTL Therapy for Ewing Sarcoma.
    Ishii M; Ando J; Yamazaki S; Toyota T; Ohara K; Furukawa Y; Suehara Y; Nakanishi M; Nakashima K; Ohshima K; Nakauchi H; Ando M
    Cancer Immunol Res; 2021 Oct; 9(10):1175-1186. PubMed ID: 34385178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular assessment of circulating exosomes toward liquid biopsy diagnosis of Ewing sarcoma family of tumors.
    Zhang P; Samuel G; Crow J; Godwin AK; Zeng Y
    Transl Res; 2018 Nov; 201():136-153. PubMed ID: 30031766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Approaches to Diagnosis in Ewing Sarcoma: RT-PCR.
    Rodríguez-Martín C; Alonso J
    Methods Mol Biol; 2021; 2226():85-103. PubMed ID: 33326095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ewing's sarcoma: standard and experimental treatment options.
    Subbiah V; Anderson P; Lazar AJ; Burdett E; Raymond K; Ludwig JA
    Curr Treat Options Oncol; 2009 Apr; 10(1-2):126-40. PubMed ID: 19533369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The second European interdisciplinary Ewing sarcoma research summit--A joint effort to deconstructing the multiple layers of a complex disease.
    Kovar H; Amatruda J; Brunet E; Burdach S; Cidre-Aranaz F; de Alava E; Dirksen U; van der Ent W; Grohar P; Grünewald TG; Helman L; Houghton P; Iljin K; Korsching E; Ladanyi M; Lawlor E; Lessnick S; Ludwig J; Meltzer P; Metzler M; Mora J; Moriggl R; Nakamura T; Papamarkou T; Radic Sarikas B; Rédini F; Richter GH; Rossig C; Schadler K; Schäfer BW; Scotlandi K; Sheffield NC; Shelat A; Snaar-Jagalska E; Sorensen P; Stegmaier K; Stewart E; Sweet-Cordero A; Szuhai K; Tirado OM; Tirode F; Toretsky J; Tsafou K; Üren A; Zinovyev A; Delattre O
    Oncotarget; 2016 Feb; 7(8):8613-24. PubMed ID: 26802024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.